The Management of Recurrent Ovarian Cancer-Reference-Cited by-同舟云学术

The Management of Recurrent Ovarian Cancer

Published:2007-04 Issue: Volume:34 Page:S1-S15
ISSN:0093-7754
Container-title:Seminars in Oncology
language:en
Short-container-title:Seminars in Oncology

Author:

Bukowski Ronald M.,Ozols Robert F.,Markman Maurie

Publisher

Elsevier BV

Subject

Oncology,Hematology

Reference62 articles.

1. American Cancer Society: Cancer Facts and Figures 2007. Available at: http://www.cancer.org/downloads/STT/CAFF2007PWSecured.pdf (accessed April 4, 2007)

2. Treatment of advanced-stage ovarian cancer;Ozols,1997

3. A randomized clinical trial of cisplatin/paclitaxel versus carboplatin/paclitaxel as first-line treatment of ovarian cancer;du Bois;J Natl Cancer Inst,2003

4. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: A Gynecologic Oncology Group study;Ozols;J Clin Oncol,2003

5. Mortality trends in ovarian cancer;Mant,1995

Cited by 78 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new strategy for overcoming drug resistance in liver cancer: Epigenetic regulation;Biomedicine & Pharmacotherapy;2024-07

2. Pyroptosis and the tumor immune microenvironment: A new battlefield in ovarian cancer treatment;Biochimica et Biophysica Acta (BBA) - Reviews on Cancer;2024-03

3. Indoxyl Sulfate Promotes Metastatic Characteristics of Ovarian Cancer Cells via Aryl Hydrocarbon Receptor–Mediated Downregulation of the Mas Receptor;Laboratory Investigation;2023-03

4. Discordance of PD-L1 expression in primary and metastatic ovarian high-grade serous carcinoma and its correlation with CD8 + tumor-infiltrating lymphocytes and patient prognosis;Virchows Archiv;2023-02-21

5. Weekly versus tri-weekly paclitaxel with carboplatin for first-line treatment in women with epithelial ovarian cancer;Cochrane Database of Systematic Reviews;2022-02-21